Ani Pharmaceuticals Inc

MARTINGALE ASSET MANAGEMENT L P ANIP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

23,488

Value ($000)

1,854

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,854	0.0%	23,488	12/31/2025
2025 Q3	11/13/2025	2,172	0.1%	23,714	9/30/2025
2025 Q2	8/11/2025	1,573	0.0%	24,114	6/30/2025
2025 Q1	5/14/2025	1,581	0.0%	23,615	3/31/2025
2024 Q4	2/13/2025	1,447	0.0%	26,177	12/31/2024
2024 Q3	11/14/2024	2,073	0.0%	34,740	9/30/2024
2024 Q2	8/12/2024	1,339	0.0%	21,021	6/30/2024
2024 Q1	5/14/2024	1,274	0.0%	18,431	3/31/2024
2023 Q4	2/12/2024	938	0.0%	17,020	12/31/2023
2023 Q3	11/14/2023	988	0.0%	17,020	9/30/2023
2023 Q2	8/11/2023	916	0.0%	17,021	6/30/2023
2023 Q1	5/12/2023	644	0.0%	16,221	3/31/2023
2022 Q4	2/13/2023	653	0.0%	16,221	12/31/2022
2022 Q3	11/14/2022	513	0.0%	15,926	9/30/2022
2022 Q2	8/11/2022	381	0.0%	12,826	6/30/2022
2022 Q1	5/12/2022	290	0.0%	10,309	3/31/2022
2021 Q4	2/11/2022	439	0.0%	9,508	12/31/2021
2020 Q3	11/12/2020	673	0.0%	23,809	9/30/2020
2020 Q2	8/10/2020	1,635	0.0%	50,509	6/30/2020
2020 Q1	5/11/2020	2,059	0.0%	50,513	3/31/2020
2019 Q4	2/10/2020	2,481	0.0%	40,212	12/31/2019